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Abstract
Blood flow through the heart and great vessels moves in three dimensions (3D) 
throughout time. However, the assessment of its 3D nature has been limited in the 
human body. Recent advances in magnetic resonance imaging (MRI) allow for the 
comprehensive visualization and quantification of in-vivo flow dynamics using 
four-dimensional (4D) flow MRI. In addition, this technique provides the oppor-
tunity to obtain advanced hemodynamic biomarkers such as vorticity, helicity, wall 
shear stress (WSS), pressure gradients, viscous energy loss (EL), and turbulent 
kinetic energy (TKE). This chapter will introduce 4D flow MRI which is currently 
used for blood flow visualization and advanced quantification of cardiac hemo-
dynamic biomarkers. We will discuss its advantages relative to other in-vivo flow 
imaging techniques and describe its potential clinical applications in cardiology.
Keywords: Cardiac flow, 4D flow MRI, hemodynamic biomarkers, and flow 
quantification
1. Introduction
Imaging and quantifying various characteristics of blood flow throughout the 
heart is essential in modern-day cardiology. Measuring blood velocities, pressure 
gradients, regurgitation, stasis (and much more) is one of the most important 
tools physicians have for diagnosing cardiovascular pathology, stratifying severity, 
evaluating disease progression, and determining the most effective treatment strat-
egies. Improving the accuracy and depth of such hemodynamic measurements is an 
ongoing process that continues to enhance clinical success. Two-dimensional phase-
contrast magnetic resonance imaging (2D PC-MRI) and Doppler echocardiography 
are currently the most widely used techniques for measuring cardiovascular blood 
flow in-vivo [1]. However, while these modalities provide immense value in clinical 
practice, they have their limitations. Velocity can only be measured in one direc-
tion; in Doppler echocardiography following the direction of the ultrasound beam 
and in 2D PC-MRI following the encoding direction assigned by the user. This can 
cause errors in flow measurements, depending on whether the beam/plane is placed 
at the exact location of interest and/or orthogonal to the direction of flow [2, 3]. 
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These 2D measurements often rely heavily on mathematical assumptions that are 
not always valid [2]. For example, 2D calculations of pressure gradients are known 
to underestimate pressure recovery downstream of stenosis [4]. In addition, some 
techniques provide limited viewpoints of the thoracic cavity, such as trans-thoracic 
echocardiography and trans-esophageal echocardiography [1, 5]. It is also possible 
to acquire the in-plane velocities (X and Y directions) over time (two velocities 
+ time) or the three plane velocities (X, Y, and Z directions) over time (three 
 velocities + time).
Time-resolved three-dimensional (3D) phase-contrast magnetic resonance 
imaging (i.e. 4D flow MRI) is a novel non-invasive, non-ionizing imaging technique 
that provides accurate qualitative and quantitative assessment of blood velocity in 
all three principle directions [6, 7]. This allows for enhanced accuracy of previously 
measurable parameters obtained routinely by Doppler echocardiography, such as 
velocity and reverse flow, as well as the calculation of new parameters, such as wall 
shear stress (WSS), 3D pressure gradients, and turbulent kinetic energy (TKE). 
These parameters can be retrospectively visualized and quantified in volumes 
(rather than cross sections), over the course of a cardiac cycle, and in unlimited 
viewpoints. Authors can refer to 2D, 3D, 4D, 5D or 7D flow depending on the acqui-
sition scheme used to encode the velocity directions over time. Thus, it is important 
to understand how the velocity acquisition is defined. In this chapter, 4D flow 
MRI measures 3 velocity encoded directions in a stack of planes along the cardiac 
cycle. As such, the ongoing development of 4D flow MRI provides great promise in 
improving the clinical management of cardiovascular disease.
2. Data acquisition and pre-processing
2.1 Safety and preparation
There are safety measures and recommendations that should be considered for 
subjects undergoing 4D flow MRI [6, 8]. Patients can fill out pre-imaging safety 
questionnaires that consider items that can cause a hazard or interfere with the MRI 
examination. The safety information may become frequently updated because of 
continuous and rapid changes in the MRI technology. Before starting any cardiac 
MRI study, compatible electrocardiogram (ECG) leads should be placed on the sub-
ject’s chest properly. The accurate synchronization of data acquisition with phases 
of the cardiac cycle, including different stages of contraction and relaxation, is one 
of the essential requirements for efficacious cardiac MRI exam. This technique is 
called ECG-gating. A phased-array receiver coil is required to capture the electro-
magnetic signals needed to create an image. Thus, it is important that receiver coils 
are positioned appropriately to cover the regions of interest. The use of contrast 
agents is optional in 4D flow MRI, but they can help increase the signal-to-noise 
ratio, and therefore improve the image quality.
2.2 Data acquisition
In 4D flow MRI, acquisition parameters (ex: spatial resolution, temporal resolu-
tion, field of view, etc.) are optimized and programmed into the scan protocol 
to provide the best possible imaging accuracy. Setting major scan parameters is 
primarily a fine balance between adequate temporal/spatial resolution and mini-
mized scan time. Imaging accuracy can also be affected by artifacts (i.e., distortions 
in the image that are not present in reality), of which velocity encoding (Venc) is 
an important contributor. Velocity encoding is a user-defined parameter that sets 
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the upper and lower limits of blood velocity which can be appropriately imaged for 
within the scan protocol. If the patient’s blood velocities fall above the Venc limit, 
aliasing will corrupt the image with artifacts in those locations. However, if the 
Venc range is set too high, the image can be populated with noise [9]. Furthermore, 
artifacts can arise from movement due to cardiac motion and breathing. As shown 
in Figure 1, ECG-gating compensates for cardiac motion to determine when the 
heart is most still, at which point images are acquired [10]. Simultaneously, dia-
phragmatic navigator gating compensates for breathing artifacts by similarly track-
ing movement of the patient’s diaphragm and acquiring images at the point of least 
movement [11]. This allows the patient to breath freely during the scan without 
creating breathing-related artifacts. These approaches are applied to provide the 
clearest possible images of 3D global and local blood flow characteristics. Four types 
of images are produced after acquisition: one magnitude image (shows anatomical 
structures) and three phase images (shows blood velocity along the Venc directions, 
often x, y, and z axes).
The most important limiting factor for adding 4D flow to a routine clinical 
cardiac MRI exam is long scan times associated with multidimensional imaging 
over the entire cardiac cycle. In 1990s, the total scan time was roughly 40–80 min-
utes which made difficult its routine application in clinical settings. In recent years, 
scan times have been further reduced due to ongoing progress in advanced imag-
ing techniques. Nowadays, different reconstruction techniques (parallel imaging, 
radial and Cartesian sampling, compressed sensing, etc.), in addition to enhanced 
computing power, have reduced the scan time to 3–10 minutes [12–14]. The latter is 
facilitating is penetration as a diagnostic tool. Finally, all acquired data are saved in 
the Digital Imaging and Communications in Medicine standard format in the MRI 
system database.
2.3 Pre-processing and correction
Due to a range of errors, image quality can be damaged by various factors includ-
ing noise, eddy current effects, concomitant gradient field effects (Maxell terms), 
velocity aliasing, and gradient field nonlinearity. Data pre-processing is applied to 
rectify these potential errors using several correction strategies to make 4D flow 
MRI a reliable source of 3D flow visualization and quantification, as illustrated in 
Figure 1. 
Data acquisition for 4D flow MRI. Data acquisition covering the whole heart (large orange rectangle) is 
acquired using electrocardiogram-gating and respiratory control (small orange rectangle). Three-dimensional 
velocity-encoding (right side) is used to obtain velocity-sensitive phase images which are subtracted from 
reference images to calculate blood flow velocities along all three spatial dimensions (X, Y, Z) and averaged 
magnitude visualizing anatomy over the cardiac cycle.
Hemodynamics
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Figure 2 [15]. Three-dimensional phase-contrast magnetic resonance angiography 
(3D PC-MRA) can be obtained at this stage based on acquired data from 4D flow 
MRI by several presented strategies without the need for further MRI acquisition. 
A 3D PC-MRA can display complex vascular structures and geometries of interest 
without requiring a contrast agent. It is vastly helpful in some situations, such as 
patients with contrast agent contraindication. In addition, 3D PC-MRA allows the 
user to retrospectively isolate specific volumes of interest for analysis.
However, 4D flow MRI images present difficulties for segmentation algorithms 
due to extensive variability in cardiovascular structure, geometric intricacy, low 
resolution, high background noise and motion artifacts. For that reason, manual 
segmentation remains a widely used method, but manual segmentation takes a long 
time to perform and is prone to observer variability [16]. There are some established 
semi-automatic segmentation methods [17–19] which are faster than manual seg-
mentation, nevertheless they are still operator dependent. Recent machine learning 
and artificial intelligence strategies have shown great ability to solve 4D flow MRI 
segmentation problems [20]. Machine learning algorithms are powerful techniques 
that train a machine (i.e. computer) to perform a specific task. Convolutional neural 
networks (CNNs), which is one of the deep learning techniques, forms the founda-
tion of image segmentation. U-Net is a CNN that was developed specifically for 
medical image segmentation [21]. Several recent studies that focused on advancing 
imaging segmentation techniques. Berhane et al. developed a CNN model to seg-
ment the aorta from 4D flow MRI images [22]. The performance in this study was 
compared with manual segmentations, and they reported good agreement across 
flow and diameter along the aorta. Segmentation speed was <1 second per case, 
while manual segmentation required at least 360 seconds. Bratt et al. suggested 
a network based on the U-net and residual modules [23]. They reported similar 
segmentation performance, < 0.6 seconds per case, however the manual segmenta-
tion required 238 seconds per case. Wu et al. developed a combinatorial network for 
segmenting the left ventricle (LV) [24]. They claimed that combining networks can 
increase the accuracy of the segmentation.
Figure 2. 
Data pre-processing. Acquired 4D flow images are pre-processed applying multiple corrections (panel A). 
A phase-contrast angiogram (PC-MRA) is calculated to visualize the cardiac structures and can be used for 
individual segmentation of vessels, panel B. the generated PC-MRA and/or segmentation can be used to mask 
the velocity field for appropriate visualization and analysis using planes or volumetric regions of interest, panel 
C. In this example a 58-year-old control volunteer is presented.
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2.4 Flow visualization and quantification
Before flow visualization and quantification, general data quality control, 
including visual inspection and quantitative quality control, is recommended 
to ensure internal data is consistent and accurate. Dedicated visualization and 
quantification software can be used for obtaining streamlines, pathlines, volume 
rendering, and/or maximum intensity projection (MIP). Streamlines represent a 
blood particle’s instantaneous path tangential to the velocity vector at a particular 
point of time, such as at peak systole. Pathlines represent a blood particle’s path 
over time (i.e. trajectory). Volume rendering allows us to represent voxel-by-voxel 
values in a dynamic spatial manner, given access to the entire field of view. A MIP 
is a single-plane image representing the maximum values through a given direction 
of the volume, similar to an X-ray image. Taken together, these flow visualization 
techniques reveal a wealth of information about blood flow abnormalities and 
cardiovascular disease progression. One of the most significant advantages 4D 
flow MRI is the ability to retrospectively quantify cardiac flow parameters within 
specified regions of interest. Flow can be analyzed within a specific volume that 
has been isolated via segmentation, or via a 2D cross-sectional analysis plane 
placed within a volume of interest. These analysis planes can be flexibly placed at 
any anatomical location to quantify general and advanced blood flow parameters. 
Some of these visualization and quantification methods will be illustrated in the 
following section.
3. Applications in cardiology
3.1 Congenital heart disease
Eight out of every 1000 infants are born with congenital heart disease (CHD), 
which encompasses all structural heart defects present at birth, including the great 
vessels and cardiac valves [25]. Individuals with CHD may develop many cardiac 
complications, even after surgical correction of the abnormality, including valve 
insufficiency, arrhythmias, and heart failure [25]. Tetralogy of Fallot is one of the 
most common forms of cyanotic (“blue baby”) CHD, accounting for about 10% of 
all CHD [26]. Tetralogy of Fallot involves a combination of four defects including 
right ventricular hypertrophy, aortic override, pulmonary stenosis, and a ventricu-
lar septal defect. These patients undergo multiple repeat surgeries and procedures 
over their lifetime but the hemodynamic factors contributing to the optimal quality 
of life and outcomes are understudied and poorly understood. Congenital heart 
disease can benefit from 4D flow MRI via the calculation of advanced hemody-
namic parameters, such as WSS, TKE, 3D pressure mapping, and energy loss [5]. 
For demonstration, we primarily focus on pressure mapping, but Table 1 provides 
an overview of 4D flow MRI hemodynamics in CHD.
Fluid pressure measured within the cardiovascular system is widely used in 
CHD diagnosis, such as coarctation of the aorta, pulmonary hypertension, or 
atrio-ventricular septal defects. The pressure difference across structural abnor-
malities (ex: stenosis or ventricular septal defect) or within the LV can reveal much 
about the severity of the disease. Pressure mapping, based on the measured 3D 
blood flow velocity field, can be calculated by solving the Navier–Stokes equation, 
which describes the time-varying flow of a viscous, incompressible Newtonian 
fluid [33, 34]. This method allows for the estimation of temporally and spatially 
distributed pressure gradients and across a large vessel segment or cardiac chamber, 
Figure 3. Overall, 3D pressure mapping allows us to gain a better understanding of 
Hemodynamics
6
the basic determinants of time-varying flow in healthy and diseased hearts, which 
has the potential to improve our methods for diagnosing, treating, and surgically 
correcting CHD [35, 36].
3.2 Mitral regurgitation
Approximately 10% of the general population will develop mitral regurgitation 
(MR) throughout their lifetime [37]. Mitral regurgitation is defined as systolic 
retrograde flow from the LV into the left atrium (LA). The main causes are classi-
fied as primary (structural or degenerative abnormality of mitral valve apparatus) 
or secondary (a disease of the LV interferes with function and integrity of mitral 
valve apparatus) [38]. This disorder generally progresses insidiously, as the heart 
compensates for increasing regurgitant volume via LA enlargement that partially 
relieves LV overload. Long-standing regurgitation yields poor outcomes as it may 
lead to progressively more severe regurgitation, LV failure, pulmonary hyperten-
sion, atrial fibrillation (AF), stroke, and death [39]. If MR is severe, surgery is the 
recommended treatment to prevent heart failure [1]. Thus, early detection and 
assessment is crucial, especially in elderly patients who are often ineligible for surgi-
cal intervention.
Doppler echocardiography is the most widely used tool for the assessment of 
MR. The commonly considered parameters when classifying MR severity are jet 
area, width of vena contracta, effective regurgitant orifice area, regurgitant volume, 









Collateral flow volume, 
peak velocity, valvular 
flow volume
KE, EL, flow 
connectivity 
distribution
[5, 8, 27, 28]
Tetralogy of Fallot Right heart (RA, RV, 
PA) systolic peak 
velocity, net flow, 
retrograde flow
WSS, vorticity, KE, 
EL, TKE, pressure 
drop






Flow volume, shunt 
flow volume, shunt 
ratio





Net flow, regurgitation 
volume, peak velocity




[5, 7, 8, 27, 
28, 30]
Marfan Syndrome AV Peak flow, AV flow 
volumes







Transposition of the 
Great Arteries
Net flow volumes, flow 
ratio, peak velocity
WSS, helical flow [5, 8]
Aortic Coarctation Collateral flow volume, 
peak velocity across 
stenosis
Pressure mapping, EL, 
WSS, helical flow
[5, 8, 27, 
30, 32]
CHD: congenital heart disease; AV: aortic valve; RA: right atrium; RV: right ventricle; PA: pulmonary artery; EL: 
viscous energy loss; KE: kinetic energy; PWV: pulse wave velocity; TKE: turbulent kinetic energy; WSS: wall shear 
stress.
Table 1. 
Overview of research on conventional and advanced 4D flow–derived hemodynamic parameters in CHD.
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and regurgitant fraction. However, the accuracy of standard approaches used to 
quantify these parameters can be influenced by the mechanism of regurgitation, 
direction of the jet, jet momentum, LV loading condition, LA size, and the patient’s 
blood pressure [40, 41]. It is also important to keep in mind that these standard-of-
care diagnostic tools do not permit a comprehensive in-vivo assessment of 3D blood 
flow which is critical to the study of complex 3D hemodynamics surrounding MR. 
Cardiac MRI has recently been reported as a more accurate tool for quantification of 
MR flow characteristics and severity grading [42, 43]. Advanced measures of vortex 
formation, helical flow patterns, EL, pressure mapping, and WSS have shown use-
fulness for assessment of valve-related disease using 4D flow MRI [44]. The shape 
of vortex cores have been shown to closely resemble the valve shape, while the 
vortex’s orientation is related to the LV inflow direction [45]. In demonstrating how 
to extract vortex information from 4D flow MRI, Krauter et al. showed that vortex 
shape, vorticity and kinetic energy (KE) strongly correlate with transmitral peak 
velocities [46]. Helical grade was also associated with systolic anterior motion of the 
mitral valve. Lastly, as shown in Figure 4, MR disturbs organized flow, resulting 
in a reduced contribution of left pulmonary veins to the vortical flow, potentially 
leading to less efficient ventricular filling and stasis [47].
It is important to note, however, that flow-based biomarkers still require fur-
ther exploration before they can be reliably applied to daily clinical practice. The 
construction of ‘atlases’ that depict physiologically normal blood flow patterns 
through the LA shows great promise in helping identify the clinical utility of certain 
hemodynamic parameters and personalizing diagnoses. Normally, MR treatment is 
primarily based on chamber dimensions and qualitative regurgitation severity grad-
ing [48], but it is well recognized that these measures may be insufficient to guide 
treatment strategies and require multi-modality integration. Four-dimensional flow 
Figure 3. 
Pressure mapping. Volume rendering maps of a control (left) and a patient with repaired tetralogy of 
Fallot (right). Several analysis planes, including location reference. Reference plane for pressure is in yellow. 




MRI has provided the ability to construct time-averaged 3D hemodynamic maps 
(i.e. atlases) from healthy subjects, which can then be used as a reference when 
evaluating a patient’s MR severity. For example, Goffic et al. recently developed 
strategies for the generation of KE and helicity atlases [49]. Their preliminary data 
suggest that these atlases may provide insight into hemodynamic influence on LV 
dysfunction progression and, thus, could have implications on personalized assess-
ment of MR. Such atlases can be created for any hemodynamic parameter of inter-
est and will be further elaborated on in the aortic diseases section of this chapter.
3.3 Atrial fibrillation
Atrial fibrillation is an abnormally fast heart rhythm with uncoordinated atrial 
activation and ineffective atrial contraction [50, 51]. Multiple simultaneous electrical 
signals firing within the atria lead to irregular ECG patterns and atrial activity, loss 
of coordinated atrial contractions, and inadequate ventricular filling. It is classified 
according to the duration of episodes. At an early stage, an episode of AF terminates 
within 7 days of onset and sinus rhythm is restored (paroxysmal AF). However, 
as severity progresses, the AF episode may last beyond one week (persistent AF) 
or does not terminate (permanent AF). The most common complication of AF is 
thromboembolic events such as stroke [50, 51]. Reduced LA function increases the 
risk of blood stasis and clot formation in the LA, especially the left atrial appendage 
(LAA) which is a small extension of the LA. The CHA2DS2-VASc score (accounts for 
patient history of: Congestive heart failure, Hypertension, Age > 75 years, Diabetes 
mellitus, Stroke, Vascular disease, Age between 65 and 74 years, and Sex) is cur-
rently recommended for stroke risk stratification for AF patients, based on clinical 
factors such as age, gender, and disease history [50–52]. This risk score is used to 
recommend the use of anticoagulants and further therapy. However, the score does 
not contain other individual physiologic factors, so prediction power is limited.
There have been efforts to improve diagnosis and evaluation of disease and 
risk-assessment of AF through analysis based on 4D flow measurements (Table 2). 
Although some contradictory reports exist, most of the recent studies character-
izing AF blood flow with relatively large cohorts agree that there is a significant 
decrease of LA flow velocity in both persistent and paroxysmal AF patients 
Figure 4. 
Mitral regurgitation. The presented case has mitral thickening with evidence of cleft in the anterior mitral 
leaflet. Panel A shows a whole heart streamline visualization used to locate mitral regurgitation (orange 
box). Panel B shows the velocity volume rendering of the velocity field. The mitral regurgitant jet was highly 
eccentric into the atrial wall. Panel C illustrates the multiplanar reconstruction of the velocity field which 
allows multiple views of the regurgitant jet. Evaluation led to a mild regurgitation grading with a regurgitant 
fraction of 15%.
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[54–57, 59]. Most notably, the increase of CHA2DS2-VASc score has been associated 
with reduced mean LA velocity [55, 56], which suggests 4D flow measurement may 
be able to improve risk assessment. Kinetic energy, which is proportional to the 
mean square of velocity, was also found to be markedly lower in AF patients than 
in controls [59]. Left atrial flow stasis is defined by Markl et al. [54] as the relative 
number of time frames, for each voxel, with flow velocity less than 0.1 m/s. Flow 
stasis has been confirmed by several studies to be elevated in AF patients [6, 8–10]. 
An example of a MIP for flow stasis is displayed in Figure 5. Also, flow patterns 
through the pulmonary vein into the LA have been studied [57].
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1. Velocity ↓ (mean and median showed 
most significant difference)
2. CHA2DS2-VASc score inversely 
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(in LA and LAA)
1. Individual variability of flow patterns 
in AF patients, despite the same 
CHA2DS2-VASc score
2. CHA2DS2-VASc correlated positively 












1. Mean and median LA velocity ↓, 
pulmonary vein peak velocity ↓
2. Stasis ↑










1. Residual volume ↓







and peak), stasis 
(in LA and LAA), 
KE (mean and 
peak)
1. Mean/peak velocities ↓
2. LA and LAA stasis ↑






and peak), stasis, 
vorticity, vortex 
volume
Peak velocity and vorticity are 
reproducible, stable, and exhibit similar 
interval-scan variability between cohorts
LA: left atrium; LAA: left atrial appendage; PAF: paroxysmal atrial fibrillation; AF: atrial fibrillation; AF-sinus: 
previous history of AF, but in sinus rhythm at time of imaging; AF-afib: in AF at time of imaging; KE: kinetic 
energy; CHA2DS2-VASc: stroke risk stratification system that accounts for patient history of congestive heart failure, 
hypertension, age > 75 years, diabetes mellitus, stroke, vascular disease, age between 64 and 75 years, and sex.
Table 2. 
Summary of 4D flow studies in AF.
Hemodynamics
10
In AF patients, fragmentation of LA inflow and vortex formation in the LA was 
characterized, see Figure 6. This study demonstrated that vortex size increased 
in paroxysmal AF and was associated with a greater risk score. Similar findings of 
decreased velocity and increased stasis have also been found in the LAA specifically 
[56, 59]. However, the limited spatial resolution of 4D flow MRI may not satisfy 
the minimum number of voxels needed to segment the LAA accurately and reliably 
in a certain number of cases [6]. In a recent study, reliability and reproducibility 
of 4D flow parameters in AF patients were reported [60]. Left atrial peak velocity 
Figure 5. 
Left atrial stasis maps. Maximum intensity projections of stasis using a sagittal-view (top) and a top-view 
(bottom).
Figure 6. 
Atrial vortex dynamics in atrial fibrillation.
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and vorticity were found to be more reproducible and independent of physiological 
factors than mean velocity, vortex volume and stasis.
3.4 Bicuspid aortic valve disease and Aortopathy
Bicuspid aortic valve (BAV) disease is the most common congenital valve disease, 
affecting 0.5–1.4% of the general population [61–63]. While an aortic valve normally 
contains three functional leaflets (i.e. tricuspid), a BAV contains only two. There 
are different sub-types of BAV: valves that developed with only two leaflets (Type 
0) and valves that developed with three leaflets containing a fusion between any 
adjacent pair (Type 1) [64]. Type 1 phenotypes are further subdivided depending 
on what leaflet pair is fused. Despite being a valvular malformation, BAV disease is 
closely associated with aortic dilation (BAV aortopathy) that increases patients’ risk 
of aortic aneurysms and dissections [65]. Traditionally, aortic diameters and growth 
rates have been used to stratify BAV patients at risk for aortic dissection, but these 
measures alone have been shown to possess limited prognostic value [66]. As well, 
uncertainties still exist regarding the exact pathophysiology of BAV aortopathy and 
the most effective timing of surgical intervention [67]. Thus, it is important to study 
new biomarkers that may enhance our understanding of BAV disease progression. 
Four-dimensional flow MRI has allowed the study of several new and promising 
biomarkers, such as abnormal flow patterns, WSS, and energy loss.
Eccentric flow jets and helicity are two characteristics of abnormal flow pat-
terns that have shown strong connections with aortic dilation in BAV patients. A 
tricuspid aortic valve typically produces a centered systolic jet and bulk flow that is 
parallel to the ascending aorta, while BAVs tend to produce off-centered systolic jets 
(eccentric flow jets) that lead to circumferential flow and vortices (helicity). Each 
BAV phenotype has been shown to produce its own general pattern of jet eccentric-
ity and helicity, and the direction and orientation of these abnormal flow patterns 
has been associated with patterns of aortic dilation [68–71]. For example, patients 
with right–left coronary leaflet fusion (Type 1 RL) are more likely to produce a 
flow jet aimed to the right-anterior wall that associates with dilation focused at 
the mid-ascending aorta, while right-non coronary leaflet fusion patients (Type 1 
RN) tend to produce right-posterior flow jets that associate with diffuse dilation 
extending to the aortic root and/or arch as well, Figure 7 [69, 70, 72]. Furthermore, 
Bissel et al. showed that BAV patients with normal flow jets and non-helical flow 
patterns tended to have similar aortic diameters to healthy volunteers [73]. While 
more longitudinal studies are needed to confirm causation, these studies seem to 
collectively suggest that abnormal flow patterns are connected to aortic dilation in 
BAV patients.
Wall shear stress, a measure of force exerted on the vessel wall by  flowing 
blood, has consistently shown to be elevated in the ascending aorta of BAV patients 
[69, 74, 75]. The abnormal flow patterns created by a BAV are likely responsible for 
these increased WSS forces, and WSS itself has also been associated with regions 
of aortic dilation (Figure 7) [68, 69, 71, 73]. Seminal studies conducted by Bollache 
et al. and Guzzardi et al. demonstrated a possible physiologic mechanism behind 
WSS-associated aortic dilation, showing that elevated WSS levels may trigger 
maladaptive metalloproteinase activity which leads to medial elastin fiber degenera-
tion and overall weaker connective tissue in the aortic wall [76]. Thus, it is thought 
that elevated WSS, driven by abnormal flow patterns, may be a direct mediator of 
aortopathy in BAV patients. This ability of 4D flow MRI to visualize flow patterns 
and quantify WSS may provide future clinical utility in the risk-stratification of 




Aortic stenosis (AS) refers to the narrowing of the aortic valve opening, which 
restricts blood flow from the LV to the aorta. It is the most prevalent valvular 
disease in developed countries, affecting 2.4% of those >75 years of age [77]. It 
is commonly a result of BAV disease, chronic calcification, or rheumatic fever 
(in developing countries). Aortic stenosis often leads to complications such as 
LV dysfunction, heart failure, and aortic dilation, aneurysm and dissection [78]. 
Surgical repair or valve replacement are the only known definitive treatments 
and accurate diagnosis and staging are critical for surgical decision-making [79]. 
The most widely used parameters in assessing valve function include transval-
vular pressure gradient, peak velocity, and valve area. However, up to 40% of AS 
patients present with discordant findings (ex: abnormally small valve area, but 
normal pressure gradient) that require additional imaging, and the heterogenous 
nature of onset of secondary complications (ex: different dilation patterns, dif-
ferent rates of progression, etc.) is not well understood [80]. Four-dimensional 
flow MRI research continues to enhance our understanding these issues through 
the novel measurement of 3D peak velocity, 3D pressure gradients, and fluid 
energy losses.
Peak velocity and pressure gradients across the aortic valve are key components 
in AS severity grading [79]. However, as previously mentioned, echocardiography 
and 2D PC-MRI measurements often underestimate peak velocity, due to inaccurate 
Figure 7. 
Flow patterns and wall shear stress in a control and bicuspid valve phenotype. The white dashed lines 
represent the location where the sample velocity profile was obtained. These flow profiles can estimate the shear 
stress rate, blood flow spatial deformation. Since no flow occurs through the vessel wall, the speed of the blood 
flow at the vessel boundary is zero. The near wall region is the boundary layer where the wall shear stress 
(WSS) forces occur. The WSS expresses the force per unit area exerted in the fluid direction on the local vessel 
tangent (
w
τ ). Yellow dashed lines illustrate the flow profile slope near the wall. On the top, a healthy control 
illustrates normal flow in the proximal ascending aorta. On the bottom, samples of right–left (RL) fusion and 
right-non coronary (RN) fusion illustrate abnormal flow.
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2D analysis plane placement, and overestimate pressure gradients, due to exclusion 
of downstream pressure recovery in calculations. The 3D visualization of these 
parameters using 4D flow MRI allows for more accurate identification of true peak 
velocity and a comprehensive calculation of pressure gradients that accounts for 
pressure recovery in the thoracic aorta. Due to this, 4D flow MRI may be a more 
accurate imaging modality for AS severity grading and surgical decision-making. 
Although, it should be noted that 3D pressure gradient calculations assume laminar 
flow, which may lead to inaccuracies when measuring severely stenotic flow where 
turbulence exists [33].
Fluid energy loss is an advanced hemodynamic parameter that provides infor-
mation regarding LV workload. There are two types of mutually exclusive fluid 
energy loss measurements: viscous energy loss (EL; energy lost due to friction 
between adjacent fluid layers with different velocities) and TKE (energy lost to tur-
bulence) [81]. Both measurements reflect LV output lost to abnormal flow patterns 
and, ultimately, a greater cardiac afterload. Larger fluid energy losses place greater 
workloads on the LV, which can lead to LV dysfunction and heart failure. Several 
studies have shown the presence of significantly elevated fluid energy losses in AS 
patients and explored the role of TKE in improved characterization of AS severity 
[82, 83]. Specifically, Binter et al. found TKE to be greater in AS patients compared 
to controls and demonstrated TKE to be influenced by aortic and valvular morphol-
ogy [83]. Taken together, this body of research suggests that fluid energy loss may 
provide novel AS severity measurements that are complimentary to traditional 
evaluation techniques. Lastly, it should be noted that jet eccentricity, helicity, and 
WSS measurements may serve the same purpose in the study of AS as they do in the 
study of BAV disease. These parameters have shown close associations with aortic 
dilation, a common complication in AS patients [68, 69, 73, 84, 85]. Most studies 
exploring these associations use BAV patient cohorts, since AS is a common finding 
in BAV disease.
3.6 Aortic Coarctation
Aortic coarctation (CoA) refers to a congenital narrowing of the thoracic 
aortic lumen, most often in the arch or descending portion, and accounts for 
approximately 6–8% of all congenital heart defects [86]. It often accompanies 
other congenital malformations, such as BAV (60%), aortic arch hypoplasia (18%), 
ventricular septal defect (13%), and sub AS (6%) [87]. Similar to AS, CoA causes an 
upstream increase in pressure, which may lead to LV dysfunction, aortic aneurysm 
and dissection, upper body hypertension, and stroke. Current diagnostics include 
computed tomographic angiography to image aortic structure and echocardiogra-
phy to measure peak velocities and pressure gradients across the stenotic region. 
Due to the limitations of echocardiography, 4D flow MRI may provide added utility 
in characterizing CoA via 3D measurement of peak velocity profiles and pressure 
gradients.
The application of 4D flow MRI in generating 3D peak velocity profiles and 
pressure gradients serves the same benefits as previously mentioned in other car-
diovascular disease. That is, it allows the visualization of temporally and spatially 
resolved flow patterns so that analysis planes may be placed in the most applicable 
locations and pressure recovery can be accounted for when measuring pressure 
drop across the CoA (Figure 8). Several studies to-date have found benefit in the 
use of 4D flow MRI for characterizing CoA flow patterns and evaluating post-repair 




In conclusion, 4D flow MRI is a powerful technique which can be used for 
calculating important clinical parameters. This chapter intended to introduce and 
summarize the usefulness of 4D flow for assessing cardiovascular diseases. Thanks 
to recent technical advances, 4D flow MRI has increased its use in cardiac MRI sites 
worldwide and it is in a ready-to-go state-of-art stage for clinical practicality.
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Figure 8. 
Evaluation of a coarctation of the aorta. Flow is visualized at peak systole (A) and early diastole (B). (C) 
Peak flow velocity (PV) across coarctation. This patient (male, 53 years old) has a type 1 LR BAV with severe 
aortic insufficiency (regurgitant fraction 56%), mild stenosis, coarctation measuring 21 mm, and moderate 
dilatation of the proximal ascending aorta (46 mm). LR: Left – Right coronary leaflet fusion; BAV: Bicuspid 
aortic valve.
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